Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept

Scand J Infect Dis. 2004;36(2):150-4. doi: 10.1080/00365540310017474.

Abstract

A case of recurrent Mycobacterium xenopi infection presenting as Pott's disease in a patient receiving etanercept for severe rheumatoid arthritis is described. A 49-y-old Caucasian male had received a total of 11 months of anti-mycobacterial therapy for hip infection acquired 15 months earlier; he presented with progressive back pain, which was diagnosed as Pott's disease. He had been treated with etanercept in addition to his prior immunosuppressive agents after the diagnosis of hip infection.

Publication types

  • Case Reports

MeSH terms

  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • DNA, Bacterial / analysis
  • Etanercept
  • Follow-Up Studies
  • Hip Prosthesis / adverse effects
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / complications
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium xenopi / isolation & purification*
  • Polymorphism, Restriction Fragment Length
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy*
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Recurrence
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • DNA, Bacterial
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept